Acute encephalitis after COVID-19 vaccination: A case report and literature review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acute encephalitis after COVID-19 vaccination: A case report and literature review
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2022-06-15
DOI
10.1080/21645515.2022.2082206
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses
- (2021) Andrea Pilotto et al. CLINICAL INFECTIOUS DISEASES
- ANA Investigates: Neurological Complications of COVID ‐19 Vaccines
- (2021) Adeline L. Goss et al. ANNALS OF NEUROLOGY
- Postvaccinal Encephalitis after ChAdOx1 nCov ‐19
- (2021) Frédéric Zuhorn et al. ANNALS OF NEUROLOGY
- Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination
- (2021) Alberto Vogrig et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Acute disseminated encephalomyelitis in a patient vaccinated against SARS‐CoV‐2
- (2021) Karolina Kania et al. Annals of Clinical and Translational Neurology
- Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19
- (2021) Giovanna S. Manzano et al. Neurology-Neuroimmunology & Neuroinflammation
- Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine
- (2021) Gabriel Torrealba-Acosta et al. BMJ Case Reports
- Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
- (2021) Martina Patone et al. NATURE MEDICINE
- Spectrum of neurological complications following COVID-19 vaccination
- (2021) Ravindra Kumar Garg et al. NEUROLOGICAL SCIENCES
- Autoimmune Encephalitis After SARS-CoV-2 Infection
- (2021) Cristina Valencia Sanchez et al. NEUROLOGY
- A first case of meningitis/encephalitis associated with SARS-Coronavirus-2
- (2020) Takeshi Moriguchi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Neurological manifestations of COVID-19 and other coronaviruses: a systematic review
- (2020) Alyne Oliveira Correia et al. NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH
- Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases
- (2020) Aristo Vojdani et al. CLINICAL IMMUNOLOGY
- A case of limbic encephalitis associated with asymptomatic COVID-19 infection
- (2020) Laura Zambreanu et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction
- (2018) Yahel Segal et al. Cellular & Molecular Immunology
- Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa
- (2018) Robert Dantzer PHYSIOLOGICAL REVIEWS
- Causal relationship between immunological responses and adverse reactions following vaccination
- (2018) Tetsuo Nakayama VACCINE
- An inflammatory response is essential for the development of adaptive immunity-immunogenicity and immunotoxicity
- (2016) Tetsuo Nakayama VACCINE
- Encephalitis Hospitalization Rates and Inpatient Mortality in the United States, 2000-2010
- (2014) Benjamin P. George et al. PLoS One
- Case Definitions, Diagnostic Algorithms, and Priorities in Encephalitis: Consensus Statement of the International Encephalitis Consortium
- (2013) A. Venkatesan et al. CLINICAL INFECTIOUS DISEASES
- Post-vaccination encephalomyelitis: Literature review and illustrative case
- (2008) William Huynh et al. JOURNAL OF CLINICAL NEUROSCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More